News|Articles|December 2, 2025

Mindray Debuts Resona A20 Premium Ultrasound Device at RSNA

The Resona A20 device reportedly provides advances in imaging and AI automation along with an intuitive ergonomic design for ease of use.

Offering a combination of enhanced image clarity, intuitive design and automated tools to facilitate smoother workflows, Mindray introduced the Resona A20 ultrasound system at the Radiological Society of North America (RSNA) conference.

Mindray noted that the Resona A20 provides ultra-wideband coverage and enhanced acoustic focusing and its FreeBeam beamforming technology enables improved precision with echo data.

Other features of the Resona A20 ultrasound platform include an adjustable control panel, a collapsible 27-inch monitor for ease of transport and an interface that allows clinicians to utilize customizable AI-powered profiles to bolster workflow efficiency, according to Mindray.

“(The Resona A20) delivers power through simplicity, elegance through intelligence, and performance that truly elevates the standard of care,” noted Maher Elhihi, the vice president of imaging marketing and corporate communications at Mindray North America.

For Related Content

• “Samsung to Unveil AI-Powered R20 Ultrasound System at RSNA”

• “New AI-Powered Ultrasound Feature May Enhance Planning for Peripheral IV Procedures”

• “Can a New AI-Powered Point-of-Care Ultrasound Platform Enhance Reporting Efficiency and Compliance?”

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

September 29th, 2026

ASTRO: What New Phase 3 Research Reveals About SBRT for Patients with Localized Prostate Cancer

For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.

September 28th, 2026

Can Brain MRI Surveillance Alone Be Advantageous in Monitoring Cognition for Patients with SCLC?

For patients with small cell lung cancer (SCLC), there was a 40 percent improvement in cognitive failure-free survival (CFFS) with brain MRI alone in comparison to the combination of brain MRI and prophylactic cranial irradiation (PCI), according to research presented at the ASTRO conference.

September 4th, 2026

Imaging Research Highlights from the European Society of Cardiology Congress

Catch up on the latest imaging research from the recent European Society of Cardiology (ESC) Congress.

September 29th, 2026

Top Five Radiology Video Interviews in September 2026

Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.

September 28th, 2026

Radiology and Building the Alzheimer’s Care Pathway of the Future

Given the increasing prevalence of Alzheimer’s disease and a staggering number of people with dementia who are undiagnosed, this author discusses five essential keys for radiologists and their colleagues to facilitate earlier detection, precision care treatment and monitoring to help ensure timely care and intervention.

September 28th, 2026

The Grouser in the Radiology Reading Room

Constant grumbling from an attending radiologist about the road ahead may be a sign that his or her best teaching years may be in the rear-view mirror.